Page results
-
Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
File results
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0427 - Oesophageal and gastric cancer treatment
-
FOI/2022/0428 - Free parking for staff or patients
-
FOI/2022/0431 - Outpatient appointment cancellations
-
FOI/2022/0432 - Bariatric surgery operations
-
FOI/2022/0433 - A&E attendances with effects of heat, light and sunburn
-
FOI/2022/0437 - IT infrastructure systems used at Trust
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0448 - Electronic cloud based job evaluation system
-
FOI/2022/0449 - Use of defibrotide for the treatment of Hepatic Veno-occlusive disease